D5 monoclonal antibody (Cambridge Antibody Technology/Merck & Co)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameD5 monoclonal antibody (Cambridge Antibody Technology/Merck & Co)
Drug Alias Nameanti-Gp41 human monoclonal antibodies (Cambridge Antibody Technology)anti-Gp41 monoclonal antibodies (Cambridge Antibody Technology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTransmembrane glycoprotein gp41 modulators
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune LtdMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A